da Silva, S. J. R., de Lima, S. C., da Silva, R. C., Kohl, A. and Pena, L. (2022) Viral load in COVID-19 patients: implications for prognosis and vaccine efficacy in the context of emerging SARS-CoV-2 variants. Frontiers in Medicine, 8, 836826. (doi: 10.3389/fmed.2021.836826) (PMID:35174189) (PMCID:PMC8841511)
Text
262395.pdf - Published Version Available under License Creative Commons Attribution. 736kB |
Abstract
The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an unprecedented public health crisis in the 21st century. As the pandemic evolves, the emergence of SARS-CoV-2 has been characterized by the emergence of new variants of concern (VOCs), which resulted in a catastrophic impact on SARS-CoV-2 infection. In light of this, research groups around the world are unraveling key aspects of the associated illness, coronavirus disease 2019 (COVID-19). A cumulative body of data has indicated that the SARS-CoV-2 viral load may be a determinant of the COVID-19 severity. Here we summarize the main characteristics of the emerging variants of SARS-CoV-2, discussing their impact on viral transmissibility, viral load, disease severity, vaccine breakthrough, and lethality among COVID-19 patients. We also provide a rundown of the rapidly expanding scientific evidence from clinical studies and animal models that indicate how viral load could be linked to COVID-19 prognosis and vaccine efficacy among vaccinated individuals, highlighting the differences compared to unvaccinated individuals.
Item Type: | Articles |
---|---|
Additional Information: | The work in LP’s lab was funded by the Fiocruz Inova Program and the Foundation for Science and Technology of Pernambuco – FACEPE, Brazil (Grant No. APQ-0560-2.12/19). SS was recipient of a Ph.D. fellowship sponsored by the Foundation for Science and Technology of Pernambuco (FACEPE) Brazil, (Grant No. IBPG-1321-2.12/18). AK was supported by UK Medical Research Council (Grant No. MC_UU_12014/8). |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Kohl, Professor Alain |
Authors: | da Silva, S. J. R., de Lima, S. C., da Silva, R. C., Kohl, A., and Pena, L. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research |
Journal Name: | Frontiers in Medicine |
Publisher: | Frontiers Media |
ISSN: | 2296-858X |
ISSN (Online): | 2296-858X |
Copyright Holders: | Copyright © 2022 Silva, Lima, Silva, Kohl and Pena |
First Published: | First published in Frontiers in Medicine 8: 836826 |
Publisher Policy: | Reproduced under a Creative Commons licence |
University Staff: Request a correction | Enlighten Editors: Update this record